Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance).

scientific article published on 10 November 2015

Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance). is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJROBP.2015.11.005
P932PMC publication ID4752720
P698PubMed publication ID26867878

P50authorKelly K HuntQ90520703
Judy BougheyQ92381506
Reshma JagsiQ38545755
P2093author name stringThomas A Buchholz
Bruce G Haffty
Karla V Ballman
David W Ollila
Sarah McLaughlin
Linda M McCall
P2860cites workBreast Cancer Version 2.2015.Q53546077
Using Chemotherapy Response to Personalize Choices Regarding Locoregional Therapy: A New Era in Breast Cancer Treatment?Q57304472
Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18Q77438388
Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstructionQ86872116
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trialQ95722875
Neoadjuvant therapy in the treatment of breast cancerQ27694514
Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.Q34158197
Radiation field design in the ACOSOG Z0011 (Alliance) TrialQ34451764
Regional Nodal Irradiation in Early-Stage Breast CancerQ34486386
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trialQ34919537
Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapyQ35087084
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.Q36368893
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conferenceQ37079615
Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable diseaseQ37079625
International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).Q37228051
Internal mammary nodes in breast cancer: diagnosis and implications for patient management -- a systematic reviewQ37246608
Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant setting.Q37633169
Role of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancerQ38009526
Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studiesQ38263152
Radiotherapy Issues After Neoadjuvant ChemotherapyQ40847134
DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast CancerQ41103003
Internal Mammary and Medial Supraclavicular Irradiation in Breast CancerQ41558949
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiationQ43843446
Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.Q44648834
Nationwide trends in mastectomy for early-stage breast cancerQ44729377
Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.Q46765380
The evolution of regional nodal irradiation in breast cancerQ48059157
Surgical Considerations After Neoadjuvant Chemotherapy: Breast Conservation Therapy.Q53471110
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectchemotherapyQ974135
P304page(s)493-502
P577publication date2015-11-10
P1433published inInternational Journal of Radiation Oncology Biology PhysicsQ2296252
P1476titlePatterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance).
P478volume94

Reverse relations

cites work (P2860)
Q57117791Breast cancer
Q88501523Clinical Audit of the Radiotherapy Process in Rectal Cancer: Clinical Practice Guidelines and Quality Certification Do Not Avert Variability in Clinical Practice
Q64109095Impact of radiation on local regional control in women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary lymph node dissection: Results from ACOSOG 1071 Clinical Trial
Q37126030Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer
Q46304850Neoadjuvant systemic therapy in breast cancer: use and trends in radiotherapy practice
Q90376518Patterns of post-operative irradiation in breast cancer patients submitted to neoadjuvant chemotherapy
Q37547957Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy
Q91845083Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy
Q33889349Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy